Seqens Seqens

X

Find the latest Drugs in Development and Pipeline Prospector News of Sling Therapeutics.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Sling Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
455 E. Eisenhower Pkwy Suite 300 PMB1048 Ann Arbor, MI 48108
Telephone
Telephone
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Linsitinib, an orally available, small-molecule, insulin-like growth factor I (IGF-1R) inhibitor,for the treatment of thyroid eye disease (TED) [Graves ophthalmopathy in development table], autoimmune disorders and rare diseases.


Lead Product(s): Linsitinib

Therapeutic Area: Immunology Product Name: Undisclosed

Highest Development Status: Phase II/ Phase IIIProduct Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable July 25, 2022

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY